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SUMMARY
Treatment outcome research strives towards objective estimates of disorder-specific treatment efficacy
and has been applied to most psychiatric disorders. However, due to shortcomings in outcome research
designs, problems still remain regarding the interpretation and generalisability of treatment outcomes.
This is despite the development of research methodology criteria such as the Gold Standards, currently
viewed as essential criteria for well-controlled cognitive-behavioural outcome research. The objectives
of this assignment are (a) to assess the Gold Standards as criteria for treatment outcome research by
means of a qualitative overview and evaluation of exposure treatment studies for PTSD, and (b) to
make recommendations for the expansion and/or modification of these criteria. An assessment of five
selected treatment outcome trials, based on the Gold Standards, showed significant limitations in the
scope of the Gold Standards regarding (a) the inclusion of target symptoms in the research hypotheses,
(b) estimates of treatment adherence, (c) guidelines for statistical analyses of attrition points, (d) the
ethical implementation of exposure treatment, and (e) estimates of significant clinical change. It is
concluded that the Gold Standards are not sufficient to ensure valid and reliable treatment outcomes.
Recommendations are made for the expansion of four of the existing Gold Standards parameters and
three additional criteria are proposed.
Key words: treatment outcome research, Gold Standards, post-traumatic stress disorder, exposure
therapy.
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OPSOMMING
Navorsing oor behandelingsuitkoms streef na objektiewe resultate oor die uitkoms van behandeling vir
spesifieke psigiatriese versteurings. Nogtans, weens tekortkominge in die ontwerp van uitkomsstudies,
word talle probleme steeds ervaar met die interpretasie en veralgemeenbaarheid van die resultate van
die studies. Dit is die geval ten spyte van die ontwikkeling van navorsingskriteria soos die "Gold Stan-
dards" wat huidig as die belangrikste kriteria vir uitkomsstudies op die gebied van die kognitiewe
gedragsterapie aanvaar word. Hierdie projek het ten doelom (a) die Gold Standards as kriteria vir uit-
komsnavorsing te assesseer deur middel van 'n kwalitatiewe oorsig en evaluering van vyf geselek-
teerde uitkomsstudies van blootstellingsterapie vir post-traumatiese stresversteuring, en (b) om aanbe-
velings te maak ter aanvulling enJofwysiging van die Gold Standards. Evaluasie van die studies het
betekenisvolle beperkings in die Gold Standards se omvattenheid uitgelig in terme van (a) die insluiting
van teikensimptome in die navorsingshipoteses, (b) die skatting van behandelingvoitrekking ("treat-
ment adherence"), (c) riglyne vir die statistiese analise van data oor attrisie, (d) die etiese implementer-
ing van blootstellingsterapie, en (e) skattings van betekenisvolle kliniese verandering. Dit blyk dat die
Gold Standards nie voldoende is om geldige en betroubare resultate oor behandelingsuitkomste te
verseker nie. Aanbevelings word gemaak vir die hersiening van vier van die Gold Standards kriteria en
drie addisionele kriteria word voorgestel.
Sleutelwoorde: behandelingsuitkomsnavorsing. Gold Standards, post-traumatiese stresversteuring,
blootstellingsterapie.
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CHAPTERl
INTRODUCTION
1.1 Outcome-based Research
In the United States, managed care insurance companies are increasingly insisting on therapeutic ser-
vices that are based on procedures with proven efficacy (Hickling & Blanchard, 1997). The same is
happening in South Africa, manifested through medical aid schemes that are cutting back on benefits
for psychiatric disorders (Brummer, 29 October 2003). The importance of providing empirical proof of
the efficacy of psychological treatments is evident.
Apart from a pragmatic approach to determine treatment efficacy (Nathan & Gorman; and Williams &
Sommer, cited in Wilson, Friedman, & Lindy, 2001), the empirical approach of finding research and
practice support for psychological treatment options is enjoying increasingly wider support under re-
searches (Wilson et aI., 2001). Outcome-based research is an example of such empirical approaches
(Agency for Healthcare Research and Quality [AHRQ], 2000).
Outcome-based research seeks to understand the results of particular health care practices and interven-
tions, including psychotherapeutic interventions. End results include effects that people experience,
such as a change in psychological symptoms and the ability to function more effectively. By linking the
type of interventions patients receive to the outcomes they experience, outcome research has become
the key to developing better ways to monitor and improve the quality of interventions. Itprovides cli-
nicians and patients with evidence about benefits, risks, and results of treatments so they can make
more informed decisions about their healthcare (AHRQ, 2000).
Treatment outcome research, particularly from a cognitive-behavioural perspective, has been applied to
various psychiatric disorders (Caballo, 1998). Examples include major depression (Salkovskis, Atha, &
Storer, 1990), agoraphobia (Salkovskis, Clark, & Hackmann, 1991), general anxiety disorder (Borko-
vee & Costello, 1993), social phobia (Turner, Beidel, & Cooley-Quille, 1995), obsessive-compulsive
disorder (Emmelkamp, Visser, & Hoekstra, 1988), and post-traumatic stress disorder (PTSD) (Foa et
al., 1999).
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1 . 2 Gold Standards
The development of appropriate methodology to investigate treatment outcome efficacy has become a
challenge. The Gold Standards (Foa & Meadows, 1997) have emerged as the most widely used set of
criteria for methodologically rigorous treatment outcome research (Foa, Keane, & Friedman, 2000; Foa
& Meadows, 1997; Wilson et aI., 2001). The Gold Standards were developed, under the auspices of
the International Society for Traumatic Stress Studies (ISTSS) (Foa et al., 2000), as part of a larger pro-
ject to formulate treatment guidelines for PTSD. The Gold Standards comprise of seven parameters for
planning the "ideal" outcome study (Foa & Meadows, 1997, p. 455).
a) Clearly defined target symptoms
The target syndrome (e.g., PTSD) or target symptom (e.g., distressing intrusive recollections) must be
clearly defined, to aid in diagnosis so that appropriate intervention measures are selected. It is also im-
portant to specify a threshold of symptom severity as an inclusion criterion for participants to minimize
bias in the interpretation of results. Finally, related to target symptoms, specific inclusion and exclu-
sion criteria must be delineated. This assists in the examination of outcome predictors and the relative
efficacy of treatment regardless of sample differences.
b) Reliable and valid measures
Once the population and target symptoms have been identified, assessment measures with reliable and
valid psychometric properties must be included. Studies that investigate specific diagnoses must in-
clude measures designed to yield diagnoses as well as instruments that assess symptom severity.
c) Blind evaluators
In order to minimize expectancy and demand bias, the use of blind evaluators is crucial, and entails that
the assessor of treatment outcome not be the person conducting treatment and, that participants be
trained not to reveal their treatment condition at post-treatment and follow-up assessment.
d) Assessor training
The reliability and validity of assessment of treatment outcome depends largely on the skill of the eva-
luator, and therefore necessitates the training of assessors. The minimum criteria required include de-
monstrating interrater reliability and calibrating assessment procedures during the study, in order to a-
void evaluator drift.
2
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e) Specific, manualised and replicable treatments
Specific treatments must be employed, designed to address the target syndrome. To ensure consistent
treatment delivery, the specific treatments must be detailed in treatment manuals, which will afford re-
plicability and contribute towards outcome generalisability.
j) Unbiased assignment of participants to treatments
To help ensure that observed treatment differences or similarities are due to the techniques employed
and not to extraneous factors, participants should be randomly assigned to treatment conditions or by
way of a stratified sampling approach. To separate the effects of treatment from therapists, each treat-
ment should be delivered by at least two therapists, and participants should be randomly assigned to
therapists within each condition.
g) Treatment adherence
Treatment adherence ratings aim to inform whether or not treatments were carried out according to pro-
tocol and whether certain components of one treatment drifted into another. These ratings are of im-
portance when one treatment excludes a technique that is part of competing treatment and the aim of
the study is to evaluate the importance of that technique.
The Gold Standards have not formally been evaluated in an empirical and/or review study. Harvey,
Bryant and Tarrier (2003) and Foa et al. (2000) only stated the content and value of the Gold Standards.
Maxfield and Hyer (2002) used the Gold Standards in an eye movement desensitisation and reproces-
sing (EMDR) study to investigate the relationship between methodology and treatment efficacy, and
proposed modifications to the Gold Standards to suit EMDR research. According to Foa and Meadows
(1997), the Gold Standards are "".by no means exhaustive" (p. 474), and conceded that guidelines for
statistical procedures must be included.
Despite the importance of conducting treatment outcome research and the development of research
guidelines, such as the Gold Standards, treatment outcome ambiguities regarding the efficacy of vari-
ous psychological treatments still remain (Wilson et aI., 2001). To illustrate this research dilemma,
PTSD and its cognitive-behavioural treatment are discussed in the next section.
3
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1 . 3 Post-Traumatic Stress Disorder
1 . 3 . 1 Background
Post-traumatic stress disorder is a debilitating psychiatric disorder that can affect up to 30% of people
exposed to a life threatening stressor (Foa & Meadows, 1997), with a general population prevalence of
up to 12% (Sherman, 1998). The Diagnostic and Statistical Manual for Mental Disorders (DSM-IV-
TR) (American Psychiatric Association [APA], 2002) includes six criteria in the diagnosis ofPTSD.
Firstly, there must be exposure to an extreme traumatic stressor involving direct personal experience,
witnessing or learning about an event that involves actual, threatened death, or serious injury. Second-
ly, the person's response to this event must involve intense fear, helplessness, or horror. The character-
istic symptoms resulting from the exposure to the trauma include, in the third place, persistent re-expe-
riencing of the traumatic event; fourthly, persistent avoidance of stimuli associated with the trauma and
numbing of general responsiveness, and fifthly, persistent symptoms of increased arousal. Finally, the
full symptom picture must be present for more than one month, and the disturbance must cause clini-
cally significant distress or impairment in social, occupational, or other important areas of functioning.
Since its incorporation as a diagnostic category in the DSM-III (APA, 1980), there has been a conside-
rable interest in PTSD as a diagnostic category (Foa & Meadows, 1997). This is evident from more
than 22 000 publications on PTSD up and till September 2003, according to the "PsychInfo" database.
1 . 3 . 2 Cognitive-behavioural treatment of PTSD
PTSD as a new diagnostic category provided the impetus for the development of cognitive-behavioural
treatment programs (Wilson et aI., 2001). Various cognitive-behavioural approaches have been initi-
ated, with varying degrees of effectiveness. Most notably are the exposure-based interventions, includ-
ing systematic desensitisation (Frank et aI., 1988), imaginal and in vivo exposure treatment (Foa & Ko-
zak, 1986), and EMDR (Carlson, Chemtob, Rusnak, Hedlund, & Muraoka, 1998; Shapiro, 1989), and
the anxiety management programs, including stress inoculation training (SIT) (Foa, Rothbaum, Riggs,
& Murdock, 1991; Foa, Rothbaum, & Steketee, 1993), and cognitive processing therapy (CPT) (Resick
& Schnicke, 1992).
1 . 3. 3 Imaginal and in vivo exposure therapy
In the treatment ofPTSD, any of the exposure-based treatment approaches can be used to access emo-
4
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tions associated with the traumatic event and to promote emotional processing. Experts view emotional
processing as the essential ingredient for treating PTSD (Foa & Kozak, 1986). It is however imaginal
and in vivo exposure treatment that enjoys widespread support in the literature (Harvey et aI., 2003).
Imaginal and in vivo exposure treatment typically involve some form of graduated exposure to trauma-
relevant cues, a procedure that mayor may not be accompanied by attempts to maintain a fear-antago-
nistic state such as relaxation. Exposure could include returning to the place where the traumatic event
occurred and attempting to come into contact with some of the salient contextual cues (e.g., time of day
that the traumatic incident occurred), as well as contact with other stimuli that have affective associa-
tions to the event (e.g., sounds or odours). More often, imaginal material is presented alone or in com-
bination with in vivo cues in order to help the individual access the full array of emotional structures
associated with a particular traumatic event (Foa & Meadows, 1997).
"Pure'" exposure therapy is currently viewed as a "well-established treatment" (Rothbaum &
Schwartz, 2002, p. 59) and classified by the AHRQ as a level A treatment option for PTSD (Foa et aI.,
2000), with support from controlled treatment outcome studies (Boudewyns, Hyer, Woods, Harrison, &
McCranie, 1990; Bryant, Moulds, Guthrie, Dang, & Dixon, 2003; Cooper & Clum, 1989; Fairbank &
Keane, 1982; Foa et aI., 1991, 1999; Keane, Fairbank, Caddell, & Zimering, 1989; Keane & Kaloupek,
1982; Marks, Lovell, Noshirvani, Livanou, & Thrasher, 1998; Paunovic & Óst, 2001; Resick, Nishith,
Weaver, Astin, & Feuer, 2002; Tarrier et aI., 1999; Taylor et aI., 2003).
Although exposure therapy is considered as the psychological treatment of choice for PTSD (Foa et aI.,
2000; Foa & Meadows, 1997; Rothbaum & Schwartz, 2002), empirical results indicate that cognitive-
behavioural treatment approaches, such as cognitive restructuring, play an equal or even superior role
in the amelioration ofPTSD symptoms (Resick et aI., 2002). These results raises questions regarding
the validity of exposure therapy's status, and question the methodology employed to reach these treat-
ment outcome results.
1. 4 Motivation, Problem Statement and Goals
Treatment outcome research, and in particular its methodology, have become important in determining
1 "Pure" exposure treatment may contain imaginal and/or in vivo exposure, the use of a "subjective units of distress" (SUD) scale,
and secondary relaxation training (e.g. breathing retraining) as an adjunct to the exposure components.
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optimal treatment options. The Gold Standards are accepted as essential criteria for treatment outcome
research. However, as indicated in section 1.3, results on the outcome of different treatment modalities
warrants an investigation of the methodologies employed in these outcome studies, particularly of the
Gold Standards as essential research criteria in treatment outcome research.
The objectives of this assignment are therefore (a) to assess the Gold Standards as criteria for treatment
outcome research by means of an overview and evaluation of selected exposure studies for PTSD, and
(b) to make recommendations for the expansion and/or modification of these criteria, if appropriate.
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CHAPTER2
METHODOLOGY
2 . 1 Methodology
As stated in section 1.4, this assignment investigates the scope of the Gold Standards in order to deter-
mine whether it represents sufficient criteria for valid and reliable treatment outcome research.
Consequently, an overview of selected exposure outcome studies for PTSD, adhering to the Gold Stan-
dards, is provided. The results of these studies are then assessed in terms of the methodology em-
ployed, in order to identify possible limitations and shortcomings regarding methodology, particularly
as it pertains to the Gold Standards. Finally, recommendations are made to expand and/or modify the
Gold Standards.
2 . 2 Literature Search
The Psychinfo and South African Studies databases were searched for exposure treatment outcome stu-
dies on PTSD, using the following key-words and combinations thereof: post-traumatic stress disorder,
PTSD, post-traumatic stress, exposure therapy, imaginal exposure, flooding, prolonged exposure, and
in vivo exposure. Each search was limited to available English journals and books. The reference lists
of identified references were then searched for any references that might have been overlooked during
the initial searches.
2 . 3 Inclusion Criteria for Outcome Studies
Two studies, reported in the medical literature, indicated that treatment effects were inflated by be-
tween 30% and 41% in studies of poorer methodological quality (Moher et al., cited in Harvey et al.,
2003). For this reason, the selection of treatment outcome studies for this overview was very stringent.
Stepwise inclusion criteria included:
a) Only imaginal and in vivo exposure-based randomised-control and randomised-comparison trials,
in which only specific, replicable, and manualised treatments were utilized, were considered. The
research stresses these as the most important criteria for judging the validity of outcome studies
7
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(Graziano & Raulin, 2000; Harvey et aI., 2003). After the screening, 16 studies adhered to these
inclusion criteria (Boudewyns & Hyer, 1990; Boudewyns et aI., 1990; Bryant et aI., 2003; Cooper
& Clum, 1989; Echburua, De Corral, Zubizarreta, & Sarasua, 1997; Foa et al., 1991, 1999; Keane
et aI., 1989; Marks et aI., 1998; Paunovic & Óst, 2001; Pitman, Orr, Altman, & Longpre, 1996;
Resick et aI., 2002; Richards, Lovell, & Marks, 1994; Tarrier et aI., 1999; Taylor et aI., 2003;
Thompson, Charlton, Kerry, Lee, & Turner, 1995).
b) Secondly, one of the trial's treatment conditions had to be "pure" exposure therapy (as defined on
p. 5), in order to control for the influence that confounding treatment components might have on
the comparison of results across studies. Six studies not meeting this criterion were then el imina-
ted: Boudewyns and Hyer (1990), Boudewyns et al. (1990), Cooper and Clum (1989), Echburua et
al. (1997), Pitman et al. (1996), and Thompson et al. (1995).
c) Finally, only studies published after 1997 and which adhered to all the Gold Standards were in-
cluded, as the Gold Standards were only published in 1997 by Foa and Meadows. Five studies re-
mained for overview and evaluation in this assignment: Marks et al. (1998), Foa et al. (1999), Tar-
rier et al. (1999), Resick et al. (2002), and Taylor et al. (2003).
2.4 Evaluation of Treatment Outcome Studies
2. 4 . 1 Treatment outcome methodology criteria
The methodology employed by many controlled treatment outcome studies is relatively poor (Harvey
et aI., 2003), rendering biased conclusions. Furthermore, the inconsistencies in the design and the re-
porting of trials have made the assessment of methodological quality and a comparison of outcome re-
sults across trials difficult (Sherman, 1998). It was therefore decided that the assessment of outcome
studies for this assignment must be based on stringent, but validated, criteria. Consequently, other re-
search methodology guidelines have been consulted, in addition to the Gold Standards.
2.4.1.1 APA taskforce
A Division 12 task force of the APA offered valuable guidelines on criteria for empirically validated
treatment outcome studies. A template was provided for the construction and evaluation of clinical in-
terventions in the area of behavioural health (Barlow & Hofmann, 1997). It requires that treatment
outcome research be constructed on the basis of two simultaneous axes (see Addendum 1). The first
8
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axis requires that guidelines take into consideration a given intervention's absolute and relative effi-
cacy, and the quality of the studies on which the judgement is made, as well as their replicability. The
second axis specifies guidelines that consider the applicability and feasibility of the intervention in the
local setting where it is to be offered as well as the generalisation of an intervention of established effi-
cacy.
2. 4 . 1 . 2 The CONSORT statement
In the medical field, the Consolidated Standards of Reporting Trials (CONSORT) statement (Altman et
aI., cited in Harvey et aI., 2003) was developed to address the inconsistencies in the reporting of trials,
which made the assessment of methodological quality difficult. It provides a checklist (see Addendum
2) for reporting on a study's method and design, assignment and randomisation, masking (blinding),
follow-up, analysis, reporting of results, and discussion of results.
2.4.1.3 The revised Gold Standards
In order to determine whether rigorous research methodology predicted more significant treatment ef-
fect sizes, Maxfield and Hyer (2002) quantitatively compared the Gold Standards to effect sizes from
EMDR outcome studies. Based on their results, Maxfield and Hyer (2002) identified three additional
methodological components, necessary for methodological rigour, not incorporated into the Gold Stan-
dards. These components include (1) no concurrent treatment, and refers to concurrent treatments that
can obscure true effects by diminishing construct validity, and may increase the amount of "noise" and
the likelihood of a Type II error, (2) multimodal assessment, which advocates the use of multimodal
measures that can assess a wide range of pathology and outcome predictors via interview, behavioural,
and physiological measures, and (3) adequate course of treatment, a parameter that was created to ca-
ter for the relative unpredictable amount of sessions required, as number of sessions may vary from
simple trauma (fewer sessions) to complex traumas (more sessions required). This final parameter al-
lows for the flexibility with which a treatment program can be adjusted to suit the type of problem
and/or for cases when too much treatment has been rendered to the participant.
2 . 4 . 1 . 4 Ethical practice
The ethical use of exposure therapy and the optimal method for applying it are currently debated (Foa,
Zoellner, Feeny, Hembree, & Alvarez-Conrad, 2002; Harvey et aI., 2003; Rothbaum & Schwartz,
2002). Researchers of exposure treatment for PTSD do not agree on the ethical implications of the in-
clusion of a wait-list control group into their research designs. One school of thought advocates the use
9
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of wait-list control groups to control for the possibility of natural remission (Resick et aI., 2002), while
others deem the withholding of treatment for PTSD sufferers as unethical (Petersen, cited in Paunovic
& Óst, 2001). However, no guidelines have been proposed regarding ethical questions of including
wait-list control groups.
2 . 4 . 2 Evaluation process
Based on the Gold Standards (Foa & Meadows, 1997), the CONSORT statement (Altman et aI., cited
in Harvey et aI., 2003), the revised Gold Standards (Maxfield & Hyer, 2002), and the suggestions for
external validity criteria as proposed by the AHRQ (Barlow & Hofmann, 1997), a set of criteria for use
in this assignment was developed and is shown in Table 2.1. In addition, a criterion for the ethical use
of wait-list control groups was also included (Petersen, cited in Paunovic & Óst, 2001). The 21 criteria
are grouped into seven groups. The five identified treatment outcome studies will be assessed in terms
of whether or not it has met these 21 criteria, either in full, partially, or not at all. The main methodo-
logical limitations (when three or more of the outcome studies share a specific limitation) will then be
identified and discussed.
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Table 2.1
Assessment Criteria for Treatment Outcome Studies (adapted from Barlow & Hofmann, 1997; Foa &
Meadows, 1997; Altman et aI., cited in Harvey et aI., 2003; Maxfield & Hyer, 2002)
Criterion Crite- Criterionrion Description of criteriongroup evaluatednumber
la Rationale Does the study have a scientific explanation of the rationale?
Motivation
lb Objectives Does the study have specific hypotheses?
2a Exclusion Clear description of exclusion and inclusion criteria, includingcriteria co-morbid conditions that must be excluded.
Partici-
This criterion equates to parameter one of the Gold Standards.
pants
Target symptoms must preferably extend further than Axis-I di-
2b Target agnosis, to include core symptoms of the relevant Axis-I diag-symptoms nos is (e.g., for PTSD, symptoms of re-experiencing, intrusions,
avoidance and numbing, and arousal must be specified as target
symptoms).
Reliable and This criterion relates to parameter two of the Gold Standards,
3a valid and includes specification of primary and secondary outcome
measures measures, whether a multimodal approach is taken, and if largebatteries are avoided (Harvey et al., 2003).
Measures 3b Assessor This criterion relates to parameter four of the Gold Standards,training with the addition of therapist training.
This criterion relates to parameter three of the Gold Standards,
3c Blindness and includes participant blindness to treatment allocation, and
how blindness is assessed.
Manualised, This criterion relates to parameter five of the Gold Standards,replicable,4a specific and includes detail regarding how and when the treatments
treatments were administered.
Treatment
How was sample size determined? To achieve a Power of at
least 80%, a minimum sample size of 15 is considered good
Sample size (see Dallal et al., in Marks et al., 1998). The study must further
state differences in sample size at the various points of assess-
ment, including that of treatment completers and dropouts.
4b
4c
Treatment
adherence
This criterion relates to parameter seven of the Gold Standards,
and includes adherence to and integrity of homework assign-
ments, as well as estimates of treatment integrity and therapist
characteristics.ratings.
11
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Criterion Crite- Criterionrion evaluated Description of criteriongroup number
Randomisa- This criterion relates to parameter six of the Gold Standards,5a tion process and includes what methods were used to carry out the allocationprocess, implement allocation, and ensure blindness?
Implementa- Are the procedures of the research design described in detail?
5b tion of This must include participant flow, dropouts, and deviations
Design design from the study as planned.
and
procedures 5c Statistical The motivation for choice of statistical analyses and definite in-methods elusion of relevant inferential statistics.
Do studies have a wait-list control group, or comparison group?
5d Ethical Are control group participants offered treatment? If so, is it viapractice randomisation or of choice? Do studies address participant
education regarding treatment disadvantages?
6a Numbers Does statistical analyses focus on both the intent-to-treat (ITT)analysed and completer samples?
Does the study offer pre-treatment baseline demographic and
6b Baseline data clinical characteristics, including co-morbidity, of each treat-
Results ment group?
6c Outcomes A summary of results for all primary and secondary measuresmust be given.
Clinical This includes the reporting of effect sizes, end-state function-6d improvement ing, participant ratings of social functioning, diagnosis remis-sion, and clinical improvement.
7a Interpreta- Interpretation of results, taking into account study hypotheses,tion study limitations, and sources of potential bias.
Discussion 7b Overall General interpretation of the results in the context of currentevidence evidence.
7c Generalisa- Does the study have external validity with regard to patient fea-tion sibility, socio-cultural generalisation, and cost-effectiveness?
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CHAPTER3
OVERVIEW AND EVALUATION OF TREATMENT OUTCOME STUDIES FOR EXPO-
SURE TREATMENT OF PTSD
3 . 1 Introduction
This chapter provides a qualitative overview of the five identified exposure-based treatment outcome
studies on PTSD, evaluate these studies according to the criteria described in Table 2.1, and identifies
significant methodological limitations that might restrict the validity of the treatment outcomes.
3 . 2 Overview of Outcome Studies
3. 2. 1 Marks et al. (1998)
Marks et al. (1998) conducted a randomised control trial to investigate the efficacy of prolonged expo-
sure (PE), cognitive restructuring (CR), and PE and CR combined (ECR), compared to relaxation (R).
Participants
Participants were outpatients referred between 1992 and 1995 by professionals, police and through
support programs, or who presented themselves. They were of diverse trauma origin and mixed gen-
der. Exclusion criteria were (a) ages younger than 16 years or older than 65 years, (b) suicidal intent,
(c) organic brain disorders, (d) past or present psychosis, (e) antidepressant medication beyond that of a
specified protocol, (f) alcohol misuse, and (g) past exposure treatment or cognitive treatment for PTSD.
Two "blind" clinicians, via a two-phase interview method, made the diagnosis of PTSD according to
DSM-III-R criteria. The diagnosis ofPTSD had to be present for six or more months. None ofthe
treatment groups differed from one another on demographic variables.
One hundred and nine participants met the inclusion criteria and were offered treatment. Of these, 22
refused and 87 began treatment (23 in PE, 19 in CR, 24 in ECR, and 21 in R). A further 10 dropped out
before post-treatment assessment, and 77 (20, 18, 19, and 20 in the PE, CR, EeR and R groups respec-
tively) completed 10 treatment sessions during a mean of 16 weeks. Of the 77 treatment completers,
52 (13, 12, 13, and 14 in the PE, CR, ECR and R groups respectively) completed follow-up assessment
at week 36.
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Measures
Assessment consisted of 12 primary measures, including (a) the Clinician-Administered PTSD Scale
(CAPS-2) (assessor-rated), total symptoms score and severity, (b) the Impact of Events Scale (lES), (c)
the PTSD Symptoms Scale (PSS), (d) the Beck Depression Inventory (BDI), (e) the State-Trait Anxiety
Inventory (STAl), (t) the Fear Questionnaire (FQ), (g) the General Health Questionnaire (GHQ), (h)
Global Improvement (GI) (assessor- and self-rated), (i) total of four goals (assessor- and self-rated), U)
Problem (assessor- and self-rated), and (k) Work/Social adjustment (assessor- and self-rated). Secon-
dary measures consisted of22 scales, mainly subscales of primary measures.
Treatments
Participants were randomised to one of four treatment conditions: (a) PE (n = 23), (b) CR (n = 19), (c)
ECR (n = 24), and (d) R (n = 21). The latter condition was included as a placebo control for therapist
contact and for homework practice between sessions. Two trained and experienced therapists (Lovell
and Thrasher) conducted the treatments, using a procedure manual and four treatment manuals, cover-
ing each session in each treatment condition. Participants had ten individual 90-minute sessions, ex-
cept for ECR, where sessions lasted 105 minutes. Sessions were audiotaped and rated. Cell sizes for
the treatment conditions, based on a minimum power of 80%, were estimated at a minimum of 13.
The PE consisted of imaginal exposure in sessions one to five, using the audiotaped sessions as home-
work, rating peak distress before sessions, at critical points during sessions, at the end of sessions, and
during homework in a daily diary. Sessions six through ten involved prolonged in vivo exposure with
the aid of a SUD scale. Between-session homework entailed live exposure for one hour daily, recorded
with distress levels in diaries.
Cognitive restructuring involved the protocols suggested by Beck and colleagues (see Beck, Emery,
and Green, cited in Marks et aI., 1998), excluding any exposure-based behavioural exercises.
Sessions one through five ofECR each involved 45 minutes of imaginal exposure, a 15 minute break,
then 45 minutes of CR. In sessions six through ten, the imaginal exposure was substituted with in vivo
exposure. Daily homework assignments of exposure-based exercises and cognitive tasks were encour-
aged, with daily recording of such assignments in diaries.
Progressive muscle relaxation, as proposed by Jacobsen (cited in Marks et aI., 1998), was taught to par-
ticipants in the R group. Participants were asked to do an hour's relaxation homework daily and to re-
cord anxiety during the homework in a diary.
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Procedures
Referred participants were sent a screening questionnaire. Suitable respondents had a two-hour screen-
ing interview covering diagnosis, the trauma and its aftermath, clinical features, impact, mental status,
and the Structured Clinical Interview for DSM-III-R for PTSD, other anxiety disorders, and substance
abuse. Suitable participants were rated in a second two-hour interview to confirm adherence to the in-
clusion criteria and were then randomly assigned in permuted blocks of20 to one of the four treat-
ments, stratified for personal (intended by someone) or impersonal (e.g., accidents) trauma. The thera-
pists were then randomly allocated to the groups.
Following pre-treatment assessment (week 0) by one of two blind assessors, treatment commenced,
where after assessment occurred at weeks 6, 11 (post-treatment), and at 1-,3- and 6-month follow-up.
Nonparametrie analyses were used for categorical variables, while ANCOVA's and ANOVA's were
used for continuous variables. All post-hoc comparisons were computed using least-significant differ-
ence scores (LSD), supported by Scheffé pairwise comparisons. For a few comparisons, t-tests were
done.
Results
Within PE, CR, and ECR, improvement from pre-treatment to post-treatment and from pre-treatment to
follow-up was highly significant on most primary measures. Compared to R, the PE, CR, and ECR
groups exhibited significant improvement on 11 out of the 12 primary measures at post-treatment level,
six out of 12 at I-month follow-up, and eight out of 12 at 3-month follow-up. For end-point imputation
analyses on the 12 primary measures PE, CR, and ECR improved significantly more than R from pre-
treatment to l-rnonth follow-up on seven measures and from pre-treatment to 3-month follow-up on
five measures. For pre-treatment to 6-month follow-up scores, E was significantly better than CR on
eight primary and six secondary measures, but none was significant on end-point imputation analyses
of primary measures. When change was computed for weeks 0 to 11, there was almost complete over-
lap between the confidence intervals of PE, CR, and ECR.
The effect size' estimates for PE, CR, and ECR was 1 to 2.5 from week 11 onward on most primary
measures, and higher still on some primary measures for PE and ECR at 3- and 6-month follow-up. Ef-
, Effect size was computed as the mean change since week 0 divided by the standard deviation of that change, where ~ 1.0 was re-
garded as clinically meaningful.
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feet sizes in the R group were almost always smaller than in PE, CR, and ECR but were often 1.0 or
larger. Clinical significance for each treatment condition was calculated for a few primary measures at
post-treatment level. Significant percentage improvement on the lES was 60% in PE, 50% in CR, 58%
in ECR, and 20% in R, and for the CAPS, 47% to 53% in the PE, CR, and ECR and 15% in the R.
Percentage of participants improved- was analysed for the lES, CAPS, and for GI. The PE, CR, and
ECR groups consistently improved similarly, and more than the R group. Percentage improvement at
post-treatment assessment was as follows: on the lES, 60% for PE, 50% for CR, 58% for ECR, and
20% for R, and on the CAPS, 47% to 53% for the PE, CR, and ECR groups, and 15% for R.
Of the 87 trial entrants, 74 (85%) consented to rating of audiotaped sessions by a blind assessor. Ran-
domly selected tapes were rated for 17% ofPE (34 tapes), 15% ofCR (28 tapes), 13% ofECR (25
tapes), and 8% ofR (17 tapes). Integrity ratings were satisfactory: on a scale ofO to 8 (8 = excellent),
mean ratings were similar across treatment conditions and therapists, for non-specific factors as well as
for specific factors.
Discussion
Marks and colleagues evaluated the design of their study against the Gold Standards, and in addition,
provided three more reasons to lend validity to the study's results: (a) assessors could not guess treat-
ment assignment, (b) outcome was similar regardless of various variables, and (c) measured improve-
ment was comparable to the results of previous studies. They also outlined three main limitations of
the study: (a) despite randomisation, PE and R yielded lower scores on some baseline measures than
CR and ECR, (b) in PE and ECR, non-completers at follow-up experienced symptom worsening since
the last assessment, more so than completers at the same point in time, resulting in the slight advantage
ofPE over CR at 6-month follow-up being discarded, and (c) the trial used a multi-measure approach,
thus increasing the chance of significant differences appearing randomly across groups.
On main outcomes, Marks et al. (1998) stated that, compared to previous randomised-control trials and
randomised-comparison trials, current improvement on symptom severity and comorbid depression
"". were at least as great." (p. 323). The authors accurately reported the equivocal outcomes of PE,
CR, and ECR, but concluded that PE and CR were slightly superior. Due to the restricted nature of the
2 For the lES and CAPS it was a change of2 standard deviations or more improvement since week 0; and for the GI a criterion of
markedly, much, or very much improved (Marks et aI., 1998).
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format of reporting of results, specific opinions regarding specific symptoms and dependant variables
were not discussed. Marks et al. (1998) recommended the possible synthesis of exposure therapy and
cognitive restructuring in future outcome studies.
Evaluation
Eighteen criteria were met in full (la, 2a, 3, 4, 5, 6, 7bc), and three partially (1b, 2b, 7a). Although
Marks et al. (1998) provided an appropriate rationale for their study, no experimental hypotheses were
proposed (1b). Despite a wide range of outcome measures, no analyses of core symptoms (2b) were
provided, only analyses of total scores. Due to the lack of research hypotheses, the interpretation of re-
sults did appear without context at times (7a). In addition, self-rated social improvement was lower
than assessor rated improvement, indicating that participants did not perceive personal gain from the
treatment. At post-treatment, 47% (n = 9) ofPE, 68% (n = 12) ofCR, and 68% (n = 12) of the ECR
participants did not show good end-state functioning.
Marks et al. (1998) presented a well-designed trial, and reported it systematically. The study conclu-
ded that PE and CR showed similar results in terms of clinical improvement, and were superior to
ECR. Limitations of the study included the following. Firstly, no inferential statistics on the core
symptoms ofPTSD were provided. This reduces the different treatment effects found between the
treatment conditions. Secondly, the baseline differences of dropouts at pre-treatment, and their level of
functioning at the time they terminated treatment, discounted the slight superiority ofE over Cat 6-
month follow-up. Thirdly, the large assessment battery implemented, both self- and assessor-rated,
could have increased the chances of significant differences appearing randomly across groups.
In conclusion, analyses of the Marks et al. (1998) data indicate a comparable efficacy for PE, CR, and
ECR. The disappointing results for clinical improvement do however put the actual effectiveness of
the active treatments in doubt. Irrespective of the results' valence, the heterogeneous sample (popula-
tion and trauma type), made generalisation of results to the general population more reliable.
3.2.2 Foa et al. (1999)
Rationale
Citing major research outcomes to date, Foa et al. (1999) investigated the therapeutic effects of a com-
bination of exposure therapy and Stress Inoculation Training (SIT) in reducing PTSD in female assault
victims. Participants were randomly assigned to one of three conditions: SIT, prolonged exposure
(PE), or a combination (PE-SIT), and a wait-list (WL) group. Foa and colleagues hypothesised that all
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active treatments would be superior to the WL condition, and that the PE-SIT group would be superior
to PE and SIT separately.
Participants
Participants were 96 female victims of assault (sexual or nonsexual) who met the diagnosis of PTSD
according to DSM-III-R criteria. Exclusion criteria were current schizophrenia, bipolar disorder, or-
ganic mental disorder, alcohol or drug dependence, severe suicidal ideation, or being in an ongoing in-
timate relationship with one's assailant. Treatment groups did not differ significantly on demographic
variables and pre-treatment measures of psychopathology. Twenty-one women refused treatment, 17
participants dropped out of treatment, leaving 79 completers. Dropout rate differed significantly across
groups, with more participants dropping out from the SIT and PE-SIT groups. At 12-month follow-up,
data was available for only 46 participants.
Measures
Two interview measures were used: (a) the SCID, and (b) the PSS. Faa and colleagues also utilized the
Global scale of the Social Adjustment Scale (SAS) to assess functioning in various social and occupa-
tional settings. Self-report measures included the BDI, and the STAI's State Anxiety scale. Assess-
ments were conducted at pre-treatment, post-treatment, and at follow-up at 3- (N = 56), 6- (N = 54),
and 12-months (N = 46), with various blind female assessors rating treatment outcome. All measures
except for the SCID were administered at each assessment point. Possible therapist effects were exam-
ined by means of an ANCOVA on the PSS-I, adjusting for pre-treatment severity. Blind assessors via
videotaped treatment ratings of 52 treatment components determined treatment adherence.
Procedures
Participants were screened by telephone, with a subsequent personal screening, which included the
SCID and the PSS-I. They were then randomly assigned to one of the four treatment groups. After en-
rolling 10 participants into the WL group, more were assigned to the three active treatment groups. Af-
ter the pre-treatment assessment, treatment commenced.
Treatments
Participants were randomly assigned to one of three treatment conditions: (a) PE (n = 23), (b) SIT (n =
19), (c) PE + SIT (n = 22), and (d) WL (n = 15). Seven PhD-level clinical psychologists, trained to use
a specified treatment manual, conducted treatment. These clinicians were under the ongoing supervi-
sion of Faa and Dancu. Treatment consisted of nine twice-weekly sessions, two initial sessions of 120
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minutes followed by seven sessions of 90 minutes each. Following a five-week period from pre-
treatment assessment, the WL participants were offered treatment.
Prolonged exposure consisted of imaginal and in vivo exposure, with sessions three to nine devoted ex-
plicitly to exposure activities for up to 45 - 60 minutes, using a SUD scale, including homework as-
signments of both an imaginal and in vivo nature. The protocol for PE was adapted from Faa and
Meadows (cited in Faa et aI., 1999). SIT was based on the methodology applied by Faa et al. (1991).
PE-SIT treatment followed the nine-session format and included education, training in all the SIT
skills, in vivo exposure, and imaginal exposure. Each session was conducted in the following order:
brief homework review, imaginal exposure for 30-45 minutes, training in one coping skill, and home-
work consisting of both exposure and coping skill practice. WL participants were contacted once be-
tween assessments to ascertain the need for specialized intervention.
Results
Preliminary results indicated no significant therapist effects, nor significant differences in dropout
rates. Videotapes of 63 therapy sessions (9% of the sessions) were randomly selected and rated. On
average, therapists completed 93% of the treatment components.
For scores on the PSS, BDI, and STAI-S, the PE, SIT, and PE-SIT groups yielded superior outcomes
compared to the WL group at post-treatment, for both the ITT and completer samples. Follow-up
analyses also showed significant effects on all three measures, for both the ITT (PSS, BDI, and STAl-
S) and completer (PSS, BDI, and STAI-S) samples. Simple comparisons for the ITT sample indicated
that the PE group scored lower than the WL group on all three measures, whereas the SIT and the PE-
SIT groups scored lower than WL on the PSS and BDI. For the completer sample, simple comparisons
indicated that all three active treatment groups scored significantly lower than WL participants on all
three outcome measures (pSS, BDI, and STAl).
End-state functioning was defined as a cut-off score of 20 on the PSS-I, 40 on the STAI-S, and 10 for
the BDI. At post-treatment level revealed similar results for both the ITT and the completer samples,
with 52% and 57% of the PE group respectively, 31% and 42% of the SIT group, and 27% and 36% of
the PE-SIT participants achieving satisfactory functioning, as compared to 0% of the WL completers.
Analyses for diagnostic status at post-treatment showed that 60% and 65% of the PE group, 42% and
58% of the SIT group, and 40% and 54% of the PE-SIT group, ITT and completer participants respec-
tively, lost their diagnosis. These are significant decreases relative to the WL participants, but not be-
tween the groups themselves.
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Cohen's d statistics were calculated for the effect sizes at post-treatment. The PE group yielded the
largest effect sizes for all three outcome measures compared to the SIT and PE-SIT conditions, for both
the ITT and completer samples (1.46, 1.42, and 1.32 for the PSS, BDI, and STAl respectively for the
ITT sample, and 1.92, 1.47, and 1.44 for the PSS, BDI, and STAI respectively for the completer sam-
ple).
At follow-up, simple effects analyses revealed that PE completers (n = 16 at 12-months follow-up)
scored significantly lower on the STAl than did SIT (n = 14) and PE-SIT (n = 16) completers. PTSD
diagnosis ranged between 65% and 68% at 12-months follow-up. On the SAS, the PE group scored
significantly lower than the WL group. No differences were detected between the three active treat-
ments at follow-up.
Discussion
Faa and colleagues conceded that the results did not support the hypothesis that PE-SIT would be supe-
rior to the PE and SIT conditions, but provided no plausible explanation for the apparent supremacy of
PE, except to note the lower dropout rates for PE. Instead, various factors were suggested for the "un-
expected" (p. 199) failure ofPE-SIT. Drawing on results by Marks et al. (1998), Faa et al. (1999) sug-
gested that a combination of PE and SIT might be too strenuous on participants. Two methodological
limitations that might have hampered the success of SIT were noted. The discussion was concluded
with the endorsement ofPE as an effective treatment due to the ease with which it can be administered
by non-expert clinicians.
Evaluation
Fifteen of the evaluation criteria (1, 3, 4ab, 5bc, 6, 7ab) were complied with in full, and six (2, 4c, 5ad,
7c) partially. No mention was made of the method of recruitment (2a) and referral. As in the study by
Marks et al. (1998), Foa et al. (1999) did not investigate the care symptoms ofPTSD (2b), only total
scores of outcome measures. Treatment adherence was estimated, but not homework adherence (4c).
Although participants were randomly assigned, no mention was made of the randomisation process
(5a). A wait-list control group was included (5d), and offered treatment after post-treatment assess-
ments. Whether or not these WL participants had a choice in the type of treatment received was not
mentioned. Results of the study are only partially generalisable (7c), due to the specific population and
trauma type under investigation.
Faa and colleagues concluded that PE was marginally superior to SIT and PE-SIT, and that SIT and
PE-SIT were of equal efficacy. Important sources of bias need to be taken into account. Firstly, symp-
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tom change was not analysed in enough detail. Lovell, Marks, Noshirvani, Thrasher, and Livanou
(2001) showed that additional data analyses changed previous treatment outcome results by Marks et
al. (1998). Secondly, no information is available on the level of functioning of dropouts during the ac-
tive treatment phase. Because significantly more dropouts occurred for SIT and SIT-PE during this
time, results could have underestimated the impact of these treatment conditions (according to ITT
sample analysis). Thirdly, only 48% (n = 46) of the ITT sample remained for follow-up analyses. Al-
though the follow-up sample sizes for groups were still big enough, the considerable decrease in sam-
ple size from pre-treatment does decrease the reliability of results.
Given the crucial impact that the sources of bias have on the interpretation of results, it is suggested
that the marginal superiority of PE be ignored, and that it be equated to the efficacy of SIT and PE-SIT.
In addition, results from the clinical improvement of participants are important. At 12-months follow-
up, 48% (n = 7) in PE, 58% (n = 8) in SIT, and 64% (n = 10) in PE-SIT did not achieve good end-state
functioning. For all three treatment groups, approximately 33% of participants still met PTSD diagno-
sis at 12-months follow-up. Thus, the overall benefits obtained by participants are in doubt.
3. 2. 3 Tarrier et al. (1999)
Rationale
According to Tarrier et al. (1999), confounding components in treatments make direct comparisons dif-
ficult. Tarrier et al. (1999) addressed the afore-mentioned problem by comparing imaginal exposure
(IE) to cognitive restructuring (CR), having removed all exposure elements from the CR treatment and
discussion of thoughts and emotions from the IE treatment condition. The authors advanced two com-
peting hypotheses: (a) directly changing dysfunctional beliefs and cognitions resulting from the trauma
is essential, and (b) therapeutic benefit will only result from direct exposure to trauma memories.
Participants
Primary and secondary health services referred 204 patients of mixed gender and trauma type for
screening as possible participants. PTSD diagnosis was based on DSM-IV criteria. Exclusion criteria
included current alcohol and/or substance abuse, psychotic or organic brain disorders, childhood sexual
abuse as the index trauma, inconsistent medication during and up to three months prior to participation
in the study, and receiving any concurrent psychological intervention in the six months preceding the
referral. After three phases of pre-treatment assessment, 72 participants were allocated to either an IE
(n = 35) or CR (n = 37) group, of which 62 completed treatment (IE, n = 29; CR, n = 33), and 57 (IE, n
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= 27; CR, n = 29) were available for 6-month follow-up assessment. CT participants only differed
from IE participants in that a significant number had a previous psychiatric disorder. Thirty-three
(54%) participants had current major depression, with a further 11 (18%) having past major depression.
Twenty-six (43%) were diagnosed with general anxiety disorder, 15 (25%) with panic disorder, and 6
(10%) had a simple phobia.
Measures
To assess treatment expectations and impressions, participants completed the Credibility of Treatment
Questionnaire (CTQ) and were rated by the therapist for treatment motivation on a 6-item scale.
Treatment was followed by post-treatment assessment and six-month follow-up assessment by a
"blind" assessor. Additional logistic measures' were implemented to ensure treatment "blindness" to
assessors and participants. The following assessment measures were conducted at each assessment
point: (a) the CAPS for symptom change and symptom severity, (b) the Penn Inventory (PI) for symp-
tom severity, (c) the lES for indications of intrusion and avoidance symptoms, (d) the BDI, (e) the
Beck Anxiety Inventory (BAl), and the General Health Questionnaire 28 (GHQ-28) for an indication of
general psychopathology. Two "blind" assessors rated 8.4% of the sessions for therapist adherence to
the treatment manuals.
Treatments
Treatment consisted of 16 one-hour sessions and was conducted by two of the authors (Tarrier and Pil-
grim) who frequently met for peer supervision. The CT manual was developed using the principles and
techniques suggested by Beck and Emery (cited in Tarrier et aI., 1999) and Resick and Schnicke (cited
in Tarrier et aI., 1999). Discussion of the trauma incident itself was avoided, instead therapy aimed at
eliciting participants' beliefs about the meaning of the event and attributions made following it. The IE
manual was adopted from Foa et al. (1991), and focused on exposure to the trauma memory.
Procedure
Assignment to treatment entailed a three-phase assessment process, beginning with an initial interview
and screening upon referral (phase I), followed by a fuller assessment based upon DSM-IV criteria and
the CAPS (phase II). Following phase II was a four-week baseline self-monitoring period, after which
re-assessment by the CAPS (phase III) ensured admission into the study. A "blind" clinician, using a
3 These measures included the use of separate administrative procedures between therapists and assessors, multiple coding of
(Footnote continues on next page)
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process of minimization, stratified on various demographic variables, did a software-based random al-
location of participants to the treatment conditions. During session two, participants completed the
CTQ and at the end of session five therapists rated the participants' motivation for therapy.
Results
Treatment manual adherence ratings (double rated) of 8.4% of the sessions (37 audiotapes, 7 video-
tapes) indicated excellent interrater reliability (K = .947). Dropout rates, treatment credibility, expec-
tancy of benefit, and participant motivation did not differ between the treatment groups.
Repeated measures ANOYA's indicated that for both IE and CR, all measures revealed a significant
decrease from pre-treatment to follow-up, indicating symptom improvement. There were no significant
differences between E and CR on any of the outcome measures. Individual analyses ofIE and CR in-
dicated that for lES (avoidance symptoms), lES (intrusions) and GHQ-28, changes over time did not
reach significant levels.
Pre-post effect sizes indicated larger effect sizes for CR on all measures. Assessor ratings (CAPS
Global Severity scale, GSS), compared with self-ratings (CAPS Global Improvement scale, GIS), were
used to calculate clinical significant improvement. Both these measures showed no significant differ-
ences between the treatment groups: for GSS, post-treatment IE = 41%, and CR = 33%, and follow-up
IE = 26%, and CR = 35%; for GIS, post-treatment IE = 48%, CR = 27%, follow-up IE = 26%, and CR
= 17%. At post-treatment level, IE showed non-significant superiority regarding the number of partici-
pants maintaining the PTSD diagnosis (E = 41%, CT = 58%), but this difference disappeared at follow-
up level (both E and CT = 48%).
Analysis of treatment failure indicated that significant more IE participants (IE = 9, CR = 3) worsened
on the total CAPS score between pre- and post-treatment. It was found that these non-improvers, com-
pared to the 50 improvers, rated therapy of significantly less value, were assessor rated as significantly
less motivated, and missed a significantly greater number of therapy sessions.
Discussion
Tarrier and colleagues conceded that neither of the two hypotheses posed were proved, but added that
within the realm of anxiety disorders, the failure of various cognitive-behavioural approaches to dem-
treatment allocation, independent data management, and instruction to patients not to discuss their treatment with the assessor.
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onstrate superiority was not uncommon. Apart from treatment failure causally linked to non-
compliance, no plausible explanations were given for non-compliance. The authors acknowledged
several limitations of the study, including: (a) the absence ofa wait-list control group to control for
spontaneous remission, (b) the IE and CR used differed slightly from other similar manualised forms of
treatment, and (c) treatment fidelity was not assessed in detail. The authors concluded that the results
of the study are "encouraging" (p. 17).
Evaluation
Eighteen of the evaluation criteria (1,2, 3ac, 4ab, 5, 6bcd, 7) were met in full, three partially (3b, 4c,
6a). No information is provided on assessor training (3b), and no adherence to homework was assessed
(4c). In addition, criteria used to assess treatment adherence is unclear. Statistical analyses of data
only applied to the completer sample (6a).
Tarrier and colleagues concluded that neither imaginal exposure nor cognitive restructuring was supe-
rior to one another, nor that neither treatment condition was sufficient for complete symptom reduction.
Another source of bias was the actual time frame in which treatment transpired. Treatment was
planned to take place over 16weekly sessions, but the average attendance was once every two weeks,
for this could have reduced the accumulating effect of treatment. Clinical improvement paints a
gloomy picture: participant-rated end-state functioning yielded good results for only 26% (n = 7) of the
IE group, and 17% (n = 5) of the CR group at follow-up. At 6-months follow-up, 48% oflE (n = 13)
and CR (n = 14) remained PTSD cases. Finally, both treatment conditions differed slightly from other
similar manualised forms of treatment, raising doubts concerning the generalisability of results.
From the mentioned sources of bias, it would appear that the Tarrier et al. (1999) study is limited in
two respects. Firstly, the limited generalisability due to the deviation from accepted treatment proto-
cols and secondly, results showed limited clinical improvement.
3. 2. 4 Resick et al. (2002)
Rationale
Resick et al. (2002) stated that no controlled study exists which compare cognitive processing therapy
(CPT) with other validated treatment options for PTSD-diagnosed rape victims. In order to address this
shortcoming, a randomised control trial of CPT compared to prolonged exposure (PE) and a minimal
attention wait-list condition (MA) was designed. A secondary purpose of the study was to examine the
effect of both therapies on dysfunctional cognitions, specifically self-blame and guilt. Itwas hypothe-
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sised that CPT would be more effective than PE in altering guilt cognitions.
Participants
Two hundred and sixty-seven female rape survivors were assessed for possible inclusion in the study,
with a diagnosis based on DSM-IV criteria. Exclusion criteria included current psychosis, unstable
functioning while on current medication, less than three months post-trauma, developmental disabili-
ties, suicidal intent and current para-suicidal behaviour, current dependence on drugs or alcohol, illiter-
acy, current involvement in an abusive relationship, incest as the index rape, and substance abuse
within six months prior to the study. Of 181 women accepted into the trial, 10 were excluded due to
emerging exclusion criteria. Of the remaining 171 women (CPT = 62; PE = 62; MA = 47), l3 never
returned and 37 dropped out. One hundred and twenty-one women completed treatment (CPT = 41, PE
= 40, MA = 40). Dropout rates did not differ significantly between CPT and PE. There were no sig-
nificant differences between the treatment groups regarding demographic variables. Approximately
85% of the sample had experienced at least one other major crime victimization in addition to the index
rape. At 3-months follow-up, participant numbers dropped to 74 (CPT = 37; PE = 37), and at 9-month
follow-up to 52 (CPT = 26; PE = 26).
Measures
Selection for participation was done via individual interviews that included the CAPS, the Structured
Interview for DSM-IV-Patient Version (SCID), and the standardised trauma interview (STI) which in-
cluded the Sexual Abuse Exposure Questionnaire (SAEQ). Self-report measures included the PSS, the
BDI, and the Trauma-Related Guilt Inventory (TRGI). In order to assess the expectancy of therapeutic
outcome, Resick and colleagues administered a qualitative questionnaire designed by Foa et al. (1991)
at pre- and post-treatment. "Blind" evaluators assessed treatment adherence and therapist competence.
All sessions were videotaped and available for random assessment, which focused on sections on
unique and essential elements specific to each session, essential but not unique elements, acceptable but
not necessary elements, and prescribed elements for each therapy (Nishith & Resick, cited in Resick et
al.,2002).
Treatments
Resick et al. (2002) randomly assigned participants to one of three treatment conditions: PE (n = 40),
CPT (n = 41), or MA (n = 40). Eight female therapists conducted therapy, with doctoral training in
cognitive-behaviour therapy and additional training in CPT and PE. Continuous supervision was pro-
vided throughout the study. Each therapist handled approximately an equal number of cases in each
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condition. The two active treatment conditions comprised of 90 minutes sessions, for a total of 13
hours oftreatment, spanning six weeks. Both PE and CPT involved considerable homework assign-
ments, but due to treatment protocols, the two treatments' homework loads could not be equated, re-
sulting in PE participants having significantly more homework.
Prolonged exposure was conducted according to the protocol developed by Foa and Rothbaum (cited in
Resick et al., 2002) and Foa et al. (cited in Resick et al., 2002), and included psycho-education, breath-
ing retraining, and imaginal and in vivo exposure. Homework involved listening to tapes of the imagi-
nal sessions and engaging in in vivo behavioural exercises. Cognitive processing therapy followed the
manual by Resick and Schnicke (cited in Resick et aI., 2002), with only minor modifications, and in-
cluded psycho-education, written narratives on several topics, and cognitive therapy based on emergent
themes from the narratives. The MA condition served as a wait-list control group. Participants in MA
were ensured of therapy in six weeks time, with diagnostic check-ups every two weeks to rule out
emergency intervention. Various measures were put in place to ensure that MA participants had access
to immediate therapeutic intervention if they required it.
Procedures
Screening of participants was followed by random allocation of participants to one of the two treatment
conditions, after which pre-treatment assessment took place. Interrater reliability of the interview and
screening process was established by having videotapes of the sessions rated independently by senior
faculty members. Interrater reliability reached Kappa (K) values in excess of .69 for all symptom crite-
ria measured. Treatment followed, with the two active treatments completed in six weeks. At the end
of the post-treatment assessment, MA participants were randomly assigned to either CPT or PE. Fol-
low-up assessments were done at 3- and 9-months after post-treatment.
Results
Interrater reliability of the interview and screening process, treatment adherence, and therapist compe-
tence were all judged to be satisfactory in every treatment condition. Therapy outcome expectancies
indicated no significant differences between treatment completers and dropouts, or between the partici-
pants of the two active treatments.
Analyses of variance results from the ITT sample, using the "last observations carried forward" method
indicated significant differences between the groups on the CAPS and BDI at post-treatment. A post-
hoc Tukey test indicated that from pre-treatment to follow-up, both the CPT group and PE group
scored significantly lower than the MA group on the CAPS and BDI. Multivariate ANOVA's for each
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group across the four assessment periods indicated that both the CPT and PE groups changed signifi-
cantlyover time, but not from post-treatment to follow-up. Random regression analyses for CAPS and
BDI scores confirmed the results obtained.
Effect sizes for the two active treatments were calculated using Hedges g effect sizes.' The CPT and
PE groups showed larger effect sizes for symptom change, relative to the MA group. Comparing the
CPT and PE groups directly, CPT resulted in small but positive effect-size differences for PTSD, de-
pression, guilt and dysfunctional cognition measures at post-treatment, 3 months, and 9 months, indi-
cating modestly larger symptomatic improvement than for the participants in the PE group.
Multivariate ANOYA's of treatment completers yielded significant interaction, treatment group, and
session effects for CAPS and BDI as dependant variables. Additional ANOYA's indicated significant
post-treatment effects on the CAPS and BDI. Post hoc Tukey tests indicated that the group differences
on both the CAPS and BDI were between the MA group and the two treatment groups. On the CAPS,
both groups exhibited a strong decrease in scores from pre-treatment to post-treatment, and little in-
crease from post-treatment to the 3-month follow-up. For the PE group, CAPS scores decreased again
significantly from 3- to 9-months follow-up, to a level prior that of post-treatment. On the BDI, the
groups improved significantly from pre-treatment to post-treatment.
Both therapies had large effect sizes relative to MA at post-treatment on PTSD, depression, and guilt
scores. Relative to PE, CPT exhibited similar effect sizes as what the ITT sample yielded. However,
on the BDI, PE was moderately more superior.
At post-treatment, 47% of CPT and PE participants in the ITT sample still met PTSD diagnosis. At 3-
month follow up it was 42% for CPT and 53% for PE, and at 9-month follow-up 45% for CPT and
50% for PE. For treatment completers, only 20% in the CPT group and 18% of the PE group still met
criteria for PTSD at post-treatment. At the 3-month follow-up, 16% of CPT and 30% of PE partici-
pants was PTSD positive. At 9-month follow-up, 19% of CPT participants and 15% of PE participants
met the criteria. In the completer sample, 76% of the CPT and 58% of the PE participants reported
good end-state functioning'. At the 3-month follow-up, 72% of CPT and 50% ofPE participants re-
ported good end-state functioning. At 9-month follow-up, 64% of CPT and 68% of PE participants ex-
4 According to Cohen (cited in Resick et aI., 2002), small effect sizes are defined as 0.2; medium as 0.5; and large as 0.8.
5 Good end-state functioning was defined as a cut-off score of20 on the PSS and 10 on the BDI.
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hibiting good end-state functioning.
Analyses of dysfunctional cognitions yielded similar results. For the ITT sample, groups were different
on all four TRGI subscales (global guilt, hindsight bias; lack of justification; and wrongdoing) at post-
treatment. Again, CPT and PE yielded better results than MA, with CPT showing a tentative superior-
ity to PE. Identical results were obtained at 9-months follow-up, although no group improved signifi-
cantly from post-treatment to "follow-up. According to Resick et al. (2002), similar results were ob-
tained for the completer sample, but none of the inferential statistics were supplied in the article itself.
Discussion
Resick and colleagues stated that both CPT and PE were superior to MA. The authors conceded that
CPT was superior to PE in changing guilt cognitions on two of the four TRGI subscales, had better ef-
fect sizes, and showed a trend towards better end-state functioning. Taking into account that CPT util-
ised fewer sessions to deal directly with the trauma, the authors suggested that CPT was superior to PE
in alleviating PTSD symptoms in female rape victims. Itwas concluded that hindsight bias and lack of
justification were guilt cognitions that required more cognitive restructuring due to its idiosyncratic na-
ture, hence CPT's apparent superiority to PE.
The researchers pointed out two methodological limitations: (a) the study did not investigate a suffi-
cient number of variables that could have explained participant dropout, and (b) CPT was only tested
with female rape victims. Resick et al. (2002) called for additional outcome research on the efficacy of
CPT. The authors advocated research that would determine whether exposure and/or cognitive compo-
nents are necessary and sufficient for alleviating PTSD symptoms. Finally, the authors recommended
that "we need to begin matching clients with therapies for optimal outcomes" (p. 878), as treatment
outcome studies indicate that more than one treatment modality might be effective for a particular
condition.
Evaluation
Eighteen evaluation criteria were met in full, and three partially (5ad, 7c). Despite random treatment
allocation, no information regarding the randomisation process (5a) was available. The study included
a minimal attention wait-list group (5d), with great effort taken to ensure that participants in this group
did not experience symptom worsening. The authors acknowledged the limited generalisability of their
results (7c), as trauma type was restricted and cognitive-processing therapy has only been investigated
with rape victims.
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Resick and colleagues concluded that CPT is comparable to PE on treatment efficacy, but shows supe-
riority in alleviating two cardinal dysfunctional guilt cognitions. Two aspects of the outcome measures
must be considered. Firstly, no outcome measure for state anxiety was used, and secondly, specific
symptoms investigated focused on dysfunctional cognitions and did not include PTSD core symptoms.
Since exposure therapy focuses on alleviating state anxiety via addressing the PTSD core symptoms,
the two factors mentioned might have biased results in favour of CPT by avoiding key assessment vari-
ables.
Resick and colleagues presented a generally well-designed and reported treatment trial, with few limi-
tations in research design. Compared to previous studies, clinical improvement of participants reached
more acceptable levels. Taking into account the possible bias towards CPT regarding choice oftarget
symptoms and outcome measures, the slight superiority awarded to CPT is negated. Results are only
generalisabie to female rape victims.
3. 2. 5 Taylor et al. (2003)
Rationale
Taylor et al. (2003) conducted a comparative study to ascertain the true comparative efficacy, speed of
symptom improvement, and adverse effects of three PTSD treatments, namely exposure therapy (E),
EMDR, and relaxation training (RT), as few studies with well-controlled designs has attempted to in-
corporate EMDR into treatment.
Participants
Recruited from physician referrals and through local media advertisements, 164 participants were in-
vited for screening. Sixty participants met the inclusion/exclusion criteria and 45 participants com-
pleted treatment. Exclusion criteria included mental retardation, current psychotic disorders, and
commencement or change in dose of psychotropic medication within the past three months. The 60
participants that entered treatment represented a diverse population in terms of gender (78% = female),
race (77% = Caucasian), education (78% = college education), socio-economic status, and multiplicity
and diversity in the experienced trauma (sexual and physical assault and motor vehicle accidents most
common). Comorbid conditions included major depression (42%), panic disorder (31%), and social
anxiety disorder (12%). The ITT sample, allocated to a treatment condition, did not differ on any
demographic variables.
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Measures
Taylor et al. (2003) included primary and secondary- outcome measures. Structured interviews utilized
were the SCID-IV for intake diagnosis on Axis I, and the CAPS for PTSD symptom severity. As part
of the intake interview, an additional CAPS item (trauma-related guilt over acts of omission or com-
mission) was included as a secondary outcome measure. For the post-treatment and follow-up CAPS
interviews, questions were added to assess the occurrence of stressful life events and change in medica-
tion during treatment and follow-up. Self-report questionnaires to assess PTSD symptom severity in-
cluded the PSS. For depression, the BDI was included and trauma related anger was measured by an
item assessing the frequency of anger about the trauma events on a Lickert-type scale. Participants'
perceived treatment credibility was measured via the Reactions to Treatment Questionnaire (RTQ),
administered at the beginning of session 2.
Treatments
Participants were randomised to eight 90 minutes individual sessions of E (n = 15), EMDR (n = 15), or
RT (n = 15). Exposure and RT manuals were based on Marks et al. (1998), and EMDR on Shapiro
(1999). Marks et al.'s protocol only differs from Foa's widely used Exposure protocol (Foa et al.,
1999) in that it does not include breathing retraining. Exposure exercises occupied about 60 minutes of
each 90 minutes session, consisting of repeated imaginal exposure to sensory-related disturbing asso-
ciations, between-session exposure-related homework exercises, as well as therapist-assisted in vivo
exposure for an hour each day for four weeks. Relaxation training involved three different relaxation
exercises, which were practiced over three sessions. On selecting an exercise, participants practised it
in subsequent sessions with the aid of a therapist-read relaxation script and between-sessions using
audiotaped versions of the sessions. The EMDR sessions comprised of (a) practice in the Safe Place
exercise, (b) recall of events and associated memories, (c) inducement of eye movement, (d) reporting
of conjured associations, and (e) repetition of the process until provoked anxiety subsided. Two female
therapists conducted the treatment protocols. Both worked under the supervision of one of the authors
(Taylor), had several years of experience utilizing trauma-related therapeutic techniques, and had com-
pleted training from the EMDR Institute.
Procedure
Potential participants contacting the clinic were screened for inclusion-exclusion criteria during a tele-
6 Secondary measures assessed commonly associated PTSD symptoms (guilt, anger, dissociation, and depression).
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phone interview. Those successfully screened were invited for further assessment consisting of the
SClD-IV, CAPS, and self-report questionnaires. Assessment of participants occurred at pre-treatment,
post-treatment (one month after treatment ended) and at follow-up (four months after treatment ended).
Blind evaluators conducted these assessments.
A "blind" doctoral-level psychologist, using a random selection of audiotaped sessions, assessed inter-
rater reliability of the interview measures. Interrater agreement for the diagnosis ofPTSD was 92% (K
= .80). Seven assessors, six of who were "blind", rated randomly selected videotaped sessions, com-
prising 59% of all treatment sessions. On all treatment integrity factors assessed', interrater agreement
levels were above 86%.
Results
Analysis of results focused on treatment completers, although initial analysis indicated no significant
differences between treatments for the ITT sample.
All three treatment conditions yielded significant reductions on the four dimensions of the CAPS
scores, from pre-treatment to follow-up. Further ANCOVA's yielded only a significant time main ef-
fect for numbing. There were treatment main effects for re-experiencing and avoidance only. For re-
experiencing and avoidance symptoms, E was significantly more effective than both RT and EMDR.
Clinical significant change, for each of the four dimensions measured by the CAPS, was defined as a
reduction in scores of at least two standard deviations. At follow-up, E yielded significant better im-
provement over RT on re-experiencing, avoidance, and hyperarousal. Exposure yielded significant re-
ductions in the percentage of participants still meeting criteria for PTSD, compared to RT, at each of
the assessment periods.
Regarding secondary outcome measures, mean scores declined significantly from pre-treatment to fol-
low-up for guilt, anger, and depression for each treatment. Dissociative symptoms significantly de-
clined for the E and RT groups.
7 Such factors included: (a) whether treatment-non-specific components such as therapist warmth and rapport were adequate; (b)
whether treatment-specific components (e.g. imaginal exposure exercises) were implemented adequately; and (c) whether the ses-
sion contained a non-protocol intervention, such as cognitive restructuring during E.
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Discussion
Taylor and colleagues highlighted PE's relative superiority over both RT and EMDR. They further ar-
gued that "therapist skill" playa major part in the relative differences between treatment conditions.
Two limitations were acknowledged: (a) a moderate sample size, and (b) the chronic nature of the sam-
ple that might limit generalisation to more moderate PTSD samples.
Evaluation
Nineteen criteria were complied with in full, and three partially (4c, 5a). Omitted from treatment ad-
herence ratings (4c) was an estimation of homework adherence. Taylor et al. (2003) did not provide in-
formation on how randomisation occurred (5a).
Taylor et al. (2003) concluded that exposure therapy is a first-line psychosocial treatment for PTSD,
with only limited efficacy awarded to EMDR. They presented a well-designed and reported treatment
trial. Compared to the Resick et al. (2002) study, good remission from PTSD diagnosis for one of the
treatments (exposure therapy) was obtained, with minimal symptom worsening for EMDR. However,
no other measure was used to estimate significant clinical change. The biggest limitation of the study
is generalisation. This was the first well-controlled study to compare the efficacy ofEMDR to other
psychosocial treatments, including exposure therapy. For this study, results are valid and generalisable
to the general population (heterogeneous sample), but it is presumptuous to declare on the basis of one
study that exposure therapy is the first-line of choice as psychosocial treatment for PTSD.
3.3 Summary
Chapter 3 provided an overview of five well-controlled treatment outcome studies of exposure therapy
for PTSD (see Table 3.1, p.34, for a summary of the studies), and examined these studies' research
methodology against 21 criteria. From this evaluation, the following methodological limitations have
been identified:
a) Core symptoms ofPTSD were not sufficiently assessed in three of the studies (Marks et al., 1998;
Foa et al., 1999; Tarrier et al., 1999).
b) Detailed treatment adherence ratings were not provided. Estimates did not consistently include
homework adherence and the influence of therapist variables. Further, as little as 8% of sessions
were included for ratings (Foa et al., 1999; Marks et al., 1998; Tarrier et al., 1999), compared to
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the 59% of Taylor et al. (2003).
c) Three of the treatment outcome studies (Foa et al., 1999; Marks et al., 1998; Tarrier et al., 1999)
reported poor results in terms of significant clinical change. The "good" results reported by Taylor
et al. (2003) were only based on estimates of symptom change. Resick et al. (2002) and Taylor et
al. (2003) did not provide self-rated estimates of clinical change.
d) Statistical analyses of attrition data were insufficient. Tarrier et al. (1999) did not include analysis
of attrition data at all, while the remaining four studies utilised the "last observation carried for-
ward" (LOCF) method to analyse dropout data.
e) Two studies (Foa et al., 1999; Resick et al., 2002) utilised a wait-list control group in its research
design. This raises doubts regarding the ethical use of exposure treatment in research trials.
Findings that emerged from the evaluations in this chapter must be validated against available literature
before it can be considered significant. Chapter 4 will conclude the overview by discussing the limita-
tions, where after the final conclusions and recommendations will be outlined.
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Summary of Exposure Outcome Studies for PTSD
Study
Trauma/
target
population
Treatment nconditions Sessions
Results
Post-Test Follow-up Effectsizes
Between
treatment
conditions
Marks et al. (1998) Mixed gender,
various traumas
1. PE
2. CR
3. ECR
4. R
23
19
24
21
lO
* 1-,3-, and 6-
mo maintained
* 1,2, & 3 were superior to 4 on re-experiencing, results from
avoidance/numbing, and associated features, but post-treatment.
not on increased arousal.
* 1,2, and 3
* No differences between 1, 2, and 3 in terms of equal
improvement.
* 2, 3 improved
detachment
1,2, and 3
ranged be-
tween I &
2.5, bigger
than 4.
1=2=3>4
1. PE 23
Foa et al. (1999)
Female victims
of sexual and 2. SIT 19
nonsexual as-
sault
3. SIT+ PE 22
4. WL 15
9, twice
weekly
* 1, 2, and 3 reduced symptoms, symptom sever-
ity, depression, and state anxiety more than 4
* I> 2 & 3 in reducing anxiety (ITT)
* 1 > 3 in reducing depression
*Good end-state functioning, reduction in diag-
nostic status for all three active treatments
At I2-mo:
* Effects main-
tained
* A' . At post-
. nxiety slg- treatment:
mficantly lower PE greatest,
from post- ~ 1.44 &
treatment
~1.92*PE greatest
reduction in
state anxiety
1> 2 = 3 > 4,
but 1 not al-
ways statis-
tically sig-
nificantly
better
Mixed gender,
diverse trau- 1. E 15
* E reduced % that meet diagnostic criteria the
most
* E reduced re-experiencing, avoidance more
15 8 x 90min than EMDR & RT
each
T I I (2 03 mas, mainly 2. EMDRay or et a . 0 ) sexual/physical
assault & vehi- 3. R
cle accidents
15 * Numbing decreased the most of all 4 PTSD di-
mensions
* E improved avoidance symptoms fastest
Results
maintained
None 1>2>3
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Study
Trauma/
target
population
Treatment
conditions
Results
n Sessions Effect
sizes
Between
treatment
conditions
Mixed gender,
T . t I (1999) various traumasarrrer ea. inlv cri-mamycnme
and accidents
l.IE
2. CR
Post-Test Follow-up
1=2
Female victims I. CPT
of diverseResick et al. (2002) 2. PE
traumas,
mainly rape 3. MA
* 6-mo: All re-
sults main-
tained
* I & 2: 48%
PTSD
* 1 & 2 improved all measures, except avoidance
29 16 x 60min symptoms (lES) * 12-mo results
maintained
33 weekly 22':1
12':2
* 1 also did not improve intrusion symptoms
(lES) and diagnosis remission.
* intrusion and
avoidance
(lES) improved
from 6-mo fol-
low-up
* 1 & 2: 38%
PTSD
*Most results
maintained * Effect
* CBT =Cognitive-behavioural Therapy; CR =Cognitive Restructuring; IE = Imaginal Exposure; IT = Implosive Therapy; MA =Minimal Attention control group; PE =
Prolonged Exposure; R =Relaxation Training; ECR = PE + CR; JECR = IE + CR.
sizes in fa-
* 1, 2 > 3 in improving depression, overall PTSD *CAPS scores vour of I
symptoms, global guilt, wrongdoing cognitions. worsened from
post-treatment *2 showed
40 Bi-weekly *1 had best results regarding hindsight bias, lack to 3-mo follow- advantage
- 13h total of justification cognitions up. at 9-m fol-
41
40 low-up for
*2, CAPS PTSD
scores lowered symptoms
well from 3-mo
to 9-mo follow-
up
*1 = 2 on end-state functioning and % partici-
pants that still has diagnosis
* "Between treatment conditions" indicate the relative efficacy as concluded by the study self.
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CHAPTER4
DISCUSSION AND RECOMMENDATIONS
4 . 1 Discussion of Main Findings
Chapter 3 identified several methodological limitations of the identified treatment outcome studies, de-
spite their well-controlled status and their adherence to the Gold Standards. These limitations will now
be discussed.
4 . 1 . 1 Assessment of core PTSD symptoms
Chapter 3 revealed a lack of assessment of core PTSD symptoms across the five treatment outcome
studies. This relates very closely to the power I of a study. In any research design, the optimal balance
would be to minimise Type I errors, and to maximise power to find real differences. The more detailed
the target symptoms under investigation, the higher the power would be. However, three studies did
not address the care symptoms of PTSD (Foa et al., 1999; Marks et al., 1998; Tarrier et al., 1999).
Faa and Meadows (1997) did not specify in parameter 1 of the Gold Standards that the core symptoms
of a specific diagnostic target syndrome (e.g., PTSD) should be included in treatment outcome research
hypotheses. However, not including changes in core symptoms may lead to an increase in Type I er-
rors. This indicates a significant limitation in parameter I of the Gold Standards.
Establishing optimal power levels therefore becomes a matter of priority in terms of research design:
what is essential for the research design and what can be sacrificed (Benjafield, 1994)? In order to
compare exposure outcome results for PTSD, detailed symptom changes for all core symptoms and as-
sociated symptoms must be proved. However, by employing too many outcome measures (Marks et
aI., 1998), as a possible way of assessing more symptoms, not only increases Type I errors, but risks
"assessment fatigue" (Harvey et aI., 2003).
I Increased power relates to an increased probability of rejecting the null hypothesis; which is exactly the goal of comparison stu-
dies: to find a difference between treatment groups. However, there is a trade-off: increased power relates to an increased probabi-
lity of making Type I errors (Graziano & Raulin, 2000). The practical value hereof is that extremely high power will suggest dif-
ferences between treatments that might not be there (Benjafield, 1994).
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Since Foa and Meadows (1997) did not suggest a limit to the number of outcome measures that may be
used in research, it indicates a limitation in parameter 2 of the Gold Standards. To counter the possible
increase in Type I errors by investigating a multitude of symptoms, the number of outcome measures
can be reduced and replaced with a multimodal assessment approach. This approach will also help to
reduce "assessment fatigue" (Johnson, cited in Harvey et aI., 2003).
4 . 1 . 2 Estimates of clinical improvement
From chapter 3 it is evident that the identified studies mostly investigated improvement by quantifying
symptom change (either as good end-state functioning and/or symptom worsening), diagnosis remis-
sion and effect size estimates. Self-rated estimates of improved social functioning were found in only
two studies (Marks et al., 1998; Tarrier et al., 1999). Barlow and Hofmann (1997), Harvey et al.
(2003), and Graziano and Raulin (2000) considered it important that empirical data be analysed in
terms of the practical value of the treatment condition, thereby increasing the external validity of the
treatment (King, 1998). Barlow and Hofmann (1997) placed particular emphasis on how participant
acceptability of cost, pain, duration of treatment, and side effects influence the feasibility of a treat-
ment, and stressed the need that these variables be assessed.
The Gold Standards do not provide guidelines to estimate significant clinical change. Because the cri-
teria for clinical change are not uniform across treatment outcome studies, comparison of the results of
different studies becomes difficult. Over time, treatment outcome research have estimated such change
through (a) effect sizes, (b) PTSD diagnosis remission, (c) good end-state functioning, (d) subjective
participant ratings of social functioning (both pre- and post-treatment), and (e) significant symptom
worsening. It is therefore necessary that the Gold Standards incorporate all of these variables into a
uniform criterion to estimate clinical change.
4 . 1 . 3 Estimates of treatment adherence
Without adequate estimates of treatment adherence', the use of manualised treatments is futile (Foa &
Meadows, 1997), as a lack of control over confounding external variables' restrict the internal validity
2 The Gold Standards included "treatment integrity" and "treatment adherence" definitions under the auspice of "treatment adher-
ence" (parameter 7). This assignment adopts this viewpoint in its discussions.
3In the case of treatment adherence, these external variables include elements of therapist competence.
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of the research design (Graziano & Raulin, 2000). One study (Resick et aI., 2002) addressed treatment
adherence ratings better than the other four studies. The research design utilised independent assessors
who rated videotaped sessions according to elements necessary for each therapeutic condition to be
completed successfully. The total amount of homework completed was also rated. Limitations of the
five outcome studies included (a) the lack of homework adherence ratings (Foa et aI., 1999; Tarrier et
aI., 1999; Taylor et aI., 2003) (b) small samples of sessions rated (8% to 9% of sessions) (all studies
except Taylor et aI., 2003), and (c) incomplete criteria for ratings (not indicating specific treatment
components that are checked for) (Tarrier et aI., 1999).
Although two studies attempted to rate homework adherence (Marks et aI., 1998; Resick et aI., 2002),
assessment relied on the honesty of participants as to whether or not they actually completed home-
work assignments. In 1994, Lichstein, Riedel, and Grieve (cited in Harvey et aI., 2003) outlined three
levels of adherence to treatment. Apart from the treatment be delivered in pure form (level I) and guar-
antees that the participant has received the treatment (level IJ), the third level, "enactment" (p. 516),
must ensure that the participant has applied the treatment outside of the session. This clearly points to
the role of homework exercises.
Exposure therapy makes extensive use of both imaginal and in vivo homework exercises. Control for
homework is of cardinal importance to the success of exposure treatment, because between-session ha-
bituation of the fear network is deemed as one of the three indicators of successful emotional proces-
sing (Faa, Riggs, Massie, & Yarkzower, 1995; Marks, 1987). The fact that none of the five studies
closely monitored homework exercises indicates that a core aspect of estimating the efficacy of expo-
sure treatment has been neglected.
The APA suggested that therapist competence (including personal attributes and therapist techniques)
be rated in treatment efficacy trials (Barlow & Hofmann, 1997). However, few studies attempted to es-
timate the influence of this variable in-depth (Resick et aI., 2002; Taylor et aI., 2003). Treatment guide-
lines provided by the International Society for Traumatic Stress Studies, too, did not expand on neces-
sary therapist competence elements (Foa et aI., 2000). Since the biographical and clinical profile of
dropouts are closely scrutinised to find possible explanations for treatment failure (Marks et aI., 1998),
it is surprising that therapist competence do not feature more strongly in the evaluation of treatment
success/faiIure.
The therapeutic alliance has endured as an important variable for psychotherapy change in various
schools of psychology (Martin, Garske, & Davis, 2000). A multitude of personal attributes and thera-
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pist techniques' have been identified that may positively influence the therapeutic alliance (Ackerman
& Hilsenroth, 2003), but exposure outcome studies appear to have neglected this invaluable aspect of
treatment success. For example, Taylor et al. (2003) only investigated therapist variables as a non-
specific treatment component, rated by a blind assessor. Although a blind assessor ensures greater va-
lidity, participant ratings of therapeutic alliance factors are necessary to determine how participants
view the role of their therapist and the therapeutic relationship, the quality of which could influence
treatment adherence.
Of all Gold Standards criteria, parameter 7 ("treatment adherence") appears to be the most vague. Not
only are treatment integrity and treatment adherence grouped under the same criterion, but the scope of
the definition of treatment adherence do not require estimates of homework adherence, or the influence
of therapist competence on treatment adherence.
4 . 1 . 4 Inferential statistics for attrition
Reliable and valid statistical procedures are essential to interpret data reliably, especially to deal with
attrition that can lead to erroneous interpretations (Graziano & Raulin, 2000). This is especially appli-
cable when participants drop out due to significant factors (e.g., treatment expectations), which affect
treatment efficacy directly. By omitting attrition from data analyses, the interpretation of results will
be biased, and the generalisability of conclusions restricted when only the results from completers are
considered (Harvey et aI., 2003). The reasons why a treatment has failed for some prospective partici-
pants are as important as why a treatment was successful for others, in order to ensure better external
validity for a specific treatment (Barlow & Hofmann, 1997).
Although the usefulness of the statistical analysis of dropout data points is debated (Resick et al.,
2002), sound procedures have been used since 1992 to analyse attrition (Mazumbar, Liu, Houck, &
Reynolds, 1999), thereby countering arguments not to incorporate ITT samples in analyses. Most stud-
ies have used the "last observation carried forward" method up and till now to deal with dropout data.
However, in order to prevent misleading findings, the "last observation carried forward" method can be
supplemented with mixed-effect linear regression analysis or random regression (Gibbons et al., cited
• Therapists' personal attributes include being flexible, honest, respectful, trustworthy, confident, warm, interested, and open.
Therapist techniques include exploration, reflection, accurate interpretation, facilitating the expression of affect, and attending to
the patient's experience (Ackerman & Hilsenroth, 2003).
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in Resick et al., 2002).
Foa and Meadows (1997); and Harvey et al. (2003) admitted that the Gold Standards do not provide
adequate guidelines for the statistical analyses of outcome data.
4 . 1 . 5 Ethical implementation of exposure treatment
The ethical implementation of any treatment trial remains a contentious topic (Frueh, Turner, & Beidel,
1995). Of all treatment options for PTSD, exposure therapy receives the most attention regarding its
ethical implications and use (Rothbaum & Schwartz, 2002). However, it is still advocated practice to
include a wait-list control group in research designs (Foa et aI., 2000), despite international initiatives
to protect torture victims by forbidding such research practices (Petersen, cited in Paunovic & ast,
2001). Wait-list groups are deemed important to control for the spontaneous remission of symptoms.
Participants' rights to benevolence are the question at hand, and whether or not including a wait-list
group infringes on this right. Since none of the outcome studies investigated attrition from wait-list
groups in order to establish whether or not the waiting period deterred or harmed them, it is nearly im-
possible to answer the question.
The Gold Standards do not provide any guidelines on the ethical implementation of exposure treatment
forPTSD.
4 • 2 Conclusions and Recommendations
From the discussion in section 4.1 several limitations have been identified regarding criteria incorpo-
rated into Gold Standards. It is concluded that three of the criteria (parameter 1,2, and 7) do not pro-
vide detailed guidelines to ensure internal and external validity of research designs, and warrants rec-
ommendations to clarify these criteria. Due to the confounding definition of treatment adherence in pa-
rameter 7, it is recommended that parameter 5 (manualised and replicable treatments) necessitates
modification. The following recommendations are proposed to modify parameters 1,2,5, and 7:
Parameter 1: Clearly defined target symptoms. Target symptoms for outcome studies must extend
beyond an Axis I level of diagnoses to include the core symptoms of the syndrome under investigation.
For example, for PTSD, pre-treatment to follow-up data must include symptom clusters and symptoms
of depression and anger, which is crucial for analyses (Foa et aI., 1995; Nishith, Hearst, Mueser, & Foa,
1995).
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Parameter 2: Reliable and valid measures. Apart from measures of symptom severity and diagnosis,
reliable and valid measures must be included for: (a) treatment expectations, (b) treatment integrity, (c)
homework adherence, and (d) therapist competence. If such measures do not exist, determined re-
search efforts must address the limitation. Furthermore, the size of the assessment battery must be
minimized to avoid "assessment fatigue" and Type I errors. Limiting the research hypotheses to inves-
tigate certain core symptoms, or choosing multidimensional measures, may help serve this purpose.
Parameter 5: Specific, manualised and replicable treatments. Parameter 7 provides a confounding
definition of treatment adherence by incorporating treatment integrity and treatment adherence under
the same definition. This creates uncertainty regarding which estimates need to be included in data
analyses. It is recommended that treatment integrity ratings be separately specified and included under
parameter 5, which deals with treatment content.
Parameter 7: Treatment adherence ratings. It is recommended that the definition of treatment ad-
herence be simplified to include estimates of: (a) therapy expectations of participants, (b) homework
adherence, and (c) therapist competence.
The discussion in section 4.1 also showed limitations in the scope of the Gold Standards. Several
methodological limitations are not controlled for by the Gold Standards. Consequently, relying solely
on the Gold Standards to provide methodological soundness to a research design will not ensure suffi-
cient control over variables that may restrict generalisation of results. In order to address these limita-
tions three criteria, in addition to the Gold Standards, are proposed.
Parameter 8: Statistical methods. The Gold Standards must be expanded to include criteria for the
statistical analyses of therapeutic change as well as methods for additional analyses, such as subgroup
analyses and adjusted analyses (Harvey et aI., 2003), as well as analyses of attrition. This will also fa-
cilitate the comparison of the results from different studies.
Parameter 9: Ethical practice. The APA (Barlow & Hofmann, 1997) emphasises the ethical imple-
mentation of treatment procedures. It is recommended that the Gold Standards include guidelines and
criteria for ethical practice, particularly in terms of (a) the necessity of a wait-list control group, (b) ac-
ceptability of the treatment options to the participant, and (c) choice of treatment for wait-list partici-
pants and dropouts. One possibility, if a wait-list group must be included, is to consider the "Minimal
Attention" group approach followed by Resick et al. (2002) as an attempt to ensure that participants do
not experience adverse effects during the waiting period.
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Parameter 10: External validity. It is suggested that the Gold Standards be expanded to provide clear
guidelines on estimates of significant clinical improvement. This may so include variables such as (a)
effect sizes, (b) PTSD diagnosis remission, (c) end-state functioning, (d) subjective participant ratings
of social functioning (both pre- and post-treatment), and (e) symptom worsening. In order to ascertain
the reasons for poor or no symptom improvement and/or attrition, it is also recommended that dropouts
and poor clinical responders be contacted for a qualitative assessment of possible factors, which might
have contributed to their state of functioning, using Barlow and Hofmann's (1997) guidelines on exter-
nal validity (see Addendum 1).
4 • 3 Epilogue
Several limitations of this assignment must be acknowledged. Firstly, the fact that this study relies on
very stringent inclusion criteria and detailed evaluation criteria could be biased as too exclusive, there-
by increasing the possibility of Type II errors in drawing conclusions. There might have been signifi-
cant methodological limitations that were not detected. Secondly, this evaluation of the Gold Standards
included only exposure outcome studies ofPTSD, restricting the generalisation of findings to other
psychiatric disorders.
The Gold Standards have emerged as the most widely used criteria for cognitive-behavioural treatment
outcome research. Despite the fact that treatment outcome studies adhered to all the required guide-
lines, important methodological limitations still occurred in research designs and in the reporting of
trial results. The most notable limitation is the poor results obtained from estimates of significant clini-
cal change. Although the Gold Standards cannot control the inherent strength of a particular psycho-
logical treatment, it can provide the criteria for researchers to estimate valid changes in clinical im-
provement. This is, however, not necessarily accomplished by means of the Gold Standards, and re-
searchers are left to their own ingenuity to estimate significant clinical change and consequently create
a plethora of approaches for such estimates, thus creating dubious interpretations.
The Gold Standards were initially created for treatment outcome research on PTSD. As more empirical
research extends the Gold Standards to treatment outcome studies of other psychiatric disorders, it is
expected that these criteria will be refined and significant limitations addressed. Together with existing
methodology criteria, such as the CONSORT statement, the design and reporting of treatment outcome
trials can be put on a still higher level, thereby contributing towards increasing the external validity of
psychological treatments.
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ADDENDUM!
Template for Constructing and Evaluating Psychological Interventions (Adapted from Barlow & Hof-
mann, 1997)
Internal validity (efficacy)
1. Randomised controlled trials (RANDOM-
ISED CONTROL TRIALS) and randomised
comparison trials (Randomised comparison
trials)
2. Better than non-specific therapy
3. Better than no therapy
4. Quantified clinical observations
5. Strongly positive clinical consensus
6. Mixed clinical consensus
7. Strongly negative clinical consensus
8. Contradictory evidence
External validity (clinical utility)
1. Feasibility
• Patient acceptability (cost, pain, duration,
side-effects, etc.)
• Patient-choice in face of relatively equal
efficacy
• Probability of compliance
• Ease of disseminability (e.g., number of
practitioners with competence, require-
ments for training, opportunities for train-
ing, need for costly technologies, or addi-
tional support personnel, etc.)
2. Generalisation
• Patient characteristics
(i) cultural background issues
(ii) gender issues
(iii) developmental issues
(iv) other relevant patient characteristics
• Therapist characteristics
• Issues of robustness when applied in
practice settings with different time
frames
• Contextual factors regarding setting in
which treatment is delivered
3. Costs and benefits
• Costs of delivering intervention to indi-
vidual and society
• Costs of withholding intervention to in-
dividual and society of effective
intervention
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ADDENDUM2
Checklist ofItems included in the CONSORT Statement (adapted from Harvey et aI., 2003)
Section and topic Description
Introduction
Title and abstract Participant allocation to intervention (e.g., "randomised")
Background Scientific background and explanation of rationale
Methods
Participants
Interventions
Objectives
Outcomes
Sample size
Randomisation se-
quence generation
Allocation con-
cealment
Implementation
Blinding (masking)
Statistical methods
Inclusion criteria and settings and locations where data were collected
Details of interventions intended and method of administration
Specific objectives and hypotheses
Defined primary and secondary outcome measures
Determination of sample size and explanation of interim analyses and stop-
ping rules
Method used to generate random allocation sequence and details of restric-
tions (e.g., blocking)
Method used to implement the random allocation sequence (e.g., central tele-
phone)
Who generated allocation, assigned participants?
Did blinding occur and how was the success of blinding evaluated
Which methods used and why
Results
Participant flow Flow of participants through each stage, numbers assigned to each group,
treatment completers and analysed for the primary outcome, and deviations
from study plan
Recruitment Dates defining the periods of recruitment and follow-up
Baseline data Baseline demographic and clinical characteristics of each group
Numbers analysed Number of participants in each analysis group & whether or not it is "intent-
to-treat" analysis
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Section and topic Description
Outcomes and es- A summary of results for each group, effect size estimation and its precision
timation (e.g. 95%)
Ancillary analyses Address multiplicity: report other analysis performed
Adverse events Report all adverse or side effects
Discussion
Interpretation Interpret results, taking hypotheses, bias, and multiplicity into account
Generalisation External validity of findings
Overall evidence General interpretation of the results in the context of current evidence
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